Article | February 17, 2022

Finding The Right CDMO Partner For Tech Transfer

By Wilfredo Mateo, Director, Manufacturing Sciences & Technology, Emergent BioSolutions

GettyImages-1297414842-lab-computer

Regardless of where a drug candidate is in the development pipeline, performing a technology transfer (tech transfer) presents unique challenges for the partners involved. Overcoming these challenges is critical to ensuring the ultimate success of the product when working with a Contract Development and Manufacturing Organization (CDMO). There are a myriad of ways in which a tech transfer can fail to meet its potential – unsatisfactory yields, unforeseen materials shortages, unoptimized batch sizes that can impact the quality and timelines of the transferred product.

This is why engaging a partner with the expertise and protocols needed to conduct a comprehensive tech transfer is key to mitigating this risk. By vetting CDMOs for their regulatory track records, historical time-to-market, facilities, capabilities, and internal procedures, both companies can establish a partnership best suited to their goals.

At Emergent CDMO, customers are afforded a range of options for exploring, expanding, or expediting their manufacturing processes. With a long-standing history of commercial manufacturing success, Emergent possesses the knowledge and talent to analyze risk, perform scale-up, and optimize production, creating efficiencies and controlling costs.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Outsourced Pharma? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: